Tumor necrosis factor-α inhibits chondrogenic differentiation of synovial fibroblasts through p38 mitogen activating protein kinase pathways

References

• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–61.
   PubMed Web of Science ®Google Scholar
• Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996;149:1607–15.
   Google Scholar
• Watanabe N, Ando K, Yoshida S, Inuzuka S, Kobayashi M, Matsui N, et al. Gene expression profile analysis of rheumatoid synovial fibroblast cultures revealing the overexpression of genes responsible for tumor-like growth of rheumatoid synovium. Biochem Biophys Res Commun. 2002;294:1121–9.
   PubMed Web of Science ®Google Scholar
• Ando K, Kanazawa S, Tetsuka T, Ohta S, Jiang X, Tada T, et al. Induction of Notch signaling by tumor necrosis factor in rheu-matoid synovial fibroblasts. Oncogene. 2003;22:7796–803.
   PubMed Web of Science ®Google Scholar
• Goldring SR, Gravallese EM. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol. 2000;12:195–9.
   PubMed Web of Science ®Google Scholar
• Takayanagi H, Juji T, Miyazaki T, Iizuka H, Takahashi T, Isshiki M, et al. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J Clin Invest. 1999;104:137–46.
   PubMed Web of Science ®Google Scholar
• Romas E, Bakharevski 0, Hards DK, Kartsogiannis V, Quinn JM, Ryan PF, et al. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum. 2000;43:821–6.
   Google Scholar
• Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 2000;43:250–8.
   PubMed Web of Science ®Google Scholar
• Shigeyama Y, Pap T, Kunzler P, Simmen BR, Gay RE, Gay S. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum. 2000;43:2523–30.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Solchaga LA, Caplan AT, Yoo JU, Goldberg VM, Johnstone B. Chondroprogenitor cells of synovial tissue. Arthritis Rheum. 1999;42:2631–7.
   PubMed Web of Science ®Google Scholar
• De Ban C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44:1928–42.
   Google Scholar
• De Bari C, Dell'Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol. 2003;160:909–18.
   Google Scholar
• Shirasawa S, Sekiya I, Sakaguchi Y, Yagishita K, Ichinose S, Muneta T. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem. 2006;97:84–97.
   PubMed Web of Science ®Google Scholar
• Seto H, Kamekura S, Miura T, Yamamoto A, Chikuda H, Ogata T, et al. Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts. J Clin Invest. 2004;113:718–26.
   PubMed Web of Science ®Google Scholar
• Jones G, Halbert J, Crotty M, Shanahan EM, Batterham M, Ahem M. The effect of treatment on radiological progression in rheu-matoid arthritis: a systematic review of randomized placebo-controlled trials. Rheumatology (Oxford). 2003;42:6–13.
   PubMed Web of Science ®Google Scholar
• Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleisch-mann RM, Fox RI, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999;340:253–9.
   Google Scholar
• Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breed-veld FC, Kalden JR et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med. 2000;343:1594–602.
   Google Scholar
• Yamamoto A, Fukuda A, Seto H, Miyazaki T, Kadono Y, Sawada Y, et al. Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts. Arthritis Rheum. 2003;48:2682–92.
   PubMed Web of Science ®Google Scholar
• Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteo-clastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2000;43:259–69.
   PubMed Web of Science ®Google Scholar
• Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46:328–46
   PubMed Web of Science ®Google Scholar
• Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, Enomoto S, et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell. 1999;10:3801–13.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, et al. Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol. 2000;148:333–42.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Takahashi T, Takayanagi H, Miyazaki T, Oda H, Nakamura K, et al. Modulation of osteoclast function by ade-novirus vector-induced epidermal growth factor receptor. J Bone Miner Res. 1998;13:1714–20.
   PubMed Web of Science ®Google Scholar
• Enomoto-Iwamoto M, Nakamura T, Aikawa T, Higuchi Y, Yuasa T, Yamaguchi A, et al. Hedgehog proteins stimulate chondro-genic cell differentiation and cartilage formation. J Bone Miner Res. 2000;15:1659–68.
   Google Scholar
• Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A syn-thetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 1995;92:7686–9.
   PubMed Web of Science ®Google Scholar
• Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, et al. c-Jun N-terminal kinase is required for metalloproteinase expres-sion and joint destruction in inflammatory arthritis. J Clin Invest. 2001;108:73–81.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Miyazaki T, Kadono Y, Takayanagi H, Miura T, Nishina H, et al. Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand. J Bone Miner Res. 2002;17:612–21.
   PubMed Web of Science ®Google Scholar
• Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol. 2001;21:6461–9.
   PubMed Web of Science ®Google Scholar
• Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D, et al. Pyridinyl imidazole inhibitors of p38 mitogen- activated protein kinase bind in the ATP site. J Biol Chem. 1997;272:12116–21.
   PubMed Web of Science ®Google Scholar
• Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, et al. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. Embo J. 1996;15:1914–23.
   PubMed Web of Science ®Google Scholar
• Cheung PC, Campbell DG, Nebreda AR, Cohen P. Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. Embo J. 2003;22:5793–805.
   PubMed Web of Science ®Google Scholar
• Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol. 1994;14:5961–74.
   PubMed Web of Science ®Google Scholar
• Eerola I, Salminen H, Lammi P, Lammi M, von der Mark K, Vuorio E, et al. Type X collagen, a natural component of mouse articular cartilage: association with growth, aging, and osteoar-thritis. Arthritis Rheum. 1998;41:1287–95.
   Google Scholar
• Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001;11:372–7.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp Cell Res. 1999;250: 351–63.
   Google Scholar
• Watanabe H, de Caestecker MP, Yamada Y. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem. 2001;276:14466–73.
   PubMed Web of Science ®Google Scholar
• Then X, Wei L, Wu Q, Zhang Y, Chen Q. Mitogen-activated protein kinase p38 mediates regulation of chondrocyte differen-tiation by parathyroid hormone. J Biol Chem. 2001;276: 4879–85.
   Google Scholar
• Lories RJ, Derese I, Ceuppens JL, Luyten FP. Bone morphoge-netic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially mod-ulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum. 2003;48:2807–18.
   PubMed Web of Science ®Google Scholar
• Campbell J, Ciesielski CJ, Hunt AE, Horwood NJ, Beech JT, Hayes LA, et al. A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis. J Immunol. 2004;173:6928–37.
   PubMed Web of Science ®Google Scholar
• Westra J, Doombos-van der Meer B, de Boer P, van Leeuwen MA, van Rijswijk MH, Limburg PC. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Arthritis Res Ther. 2004;6:R384–92.
   Google Scholar
• Temming K, Lacombe M, van der Hoeven P, Prakash J, Gonzalo T, Dijkers EC, et al. Delivery of the p38 MAPkinase inhibitor 5B202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology. Bioconjug Chem. 2006;17: 1246–55.
   Google Scholar
• Mochizuki T, Muneta T, Sakaguchi Y, Nimura A, Yokoyama A, Koga H, et al. Higher chondrogenic potential of fibrous syno-vium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans. Arthritis Rheum. 2006;54:843–53.
   PubMed Web of Science ®Google Scholar
• Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005;52:2521–9.
   PubMed Web of Science ®Google Scholar